Nula Therapeutics

Nula Therapeutics pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer.

Health and bio

Nula Therapeutics raised $20M in a Seed round announced March 18, 2026, according to GlobeNewswire.

Founders and team

• CS
  Christopher Shepard Founder

  source: crunchbase.com

Raise history

1. March 18, 2026
   Seed · $20M
   Source: GlobeNewswire

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nula-therapeutics.